Cargando…
What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin?
Astaxanthin (AST) and fucoxanthin (FUC) are natural xanthophylls, having multidirectional activity, including antioxidant, anti-inflammatory, and anticancer. Both compounds also show antimicrobial activity, which is presented in this review article. There are few papers that have presented the antim...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778043/ https://www.ncbi.nlm.nih.gov/pubmed/35049891 http://dx.doi.org/10.3390/md20010036 |
_version_ | 1784637221765120000 |
---|---|
author | Karpiński, Tomasz M. Ożarowski, Marcin Alam, Rahat Łochyńska, Małgorzata Stasiewicz, Mark |
author_facet | Karpiński, Tomasz M. Ożarowski, Marcin Alam, Rahat Łochyńska, Małgorzata Stasiewicz, Mark |
author_sort | Karpiński, Tomasz M. |
collection | PubMed |
description | Astaxanthin (AST) and fucoxanthin (FUC) are natural xanthophylls, having multidirectional activity, including antioxidant, anti-inflammatory, and anticancer. Both compounds also show antimicrobial activity, which is presented in this review article. There are few papers that have presented the antimicrobial activity of AST. Obtained antimicrobial concentrations of AST (200–4000 µg/mL) are much higher than recommended by the European Food Safety Authority for consumption (2 mg daily). Therefore, we suggest that AST is unlikely to be of use in the clinical treatment of infections. Our knowledge about the antimicrobial activity of FUC is better and this compound acts against many bacteria already in low concentrations 10–250 µg/mL. Toxicological studies on animals present the safety of FUC application in doses 200 mg/kg body weight and higher. Taking available research into consideration, a clinical application of FUC as the antimicrobial substance is real and can be successful. However, this aspect requires further investigation. In this review, we also present potential mechanisms of antibacterial activity of carotenoids, to which AST and FUC belong. |
format | Online Article Text |
id | pubmed-8778043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87780432022-01-22 What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin? Karpiński, Tomasz M. Ożarowski, Marcin Alam, Rahat Łochyńska, Małgorzata Stasiewicz, Mark Mar Drugs Review Astaxanthin (AST) and fucoxanthin (FUC) are natural xanthophylls, having multidirectional activity, including antioxidant, anti-inflammatory, and anticancer. Both compounds also show antimicrobial activity, which is presented in this review article. There are few papers that have presented the antimicrobial activity of AST. Obtained antimicrobial concentrations of AST (200–4000 µg/mL) are much higher than recommended by the European Food Safety Authority for consumption (2 mg daily). Therefore, we suggest that AST is unlikely to be of use in the clinical treatment of infections. Our knowledge about the antimicrobial activity of FUC is better and this compound acts against many bacteria already in low concentrations 10–250 µg/mL. Toxicological studies on animals present the safety of FUC application in doses 200 mg/kg body weight and higher. Taking available research into consideration, a clinical application of FUC as the antimicrobial substance is real and can be successful. However, this aspect requires further investigation. In this review, we also present potential mechanisms of antibacterial activity of carotenoids, to which AST and FUC belong. MDPI 2021-12-29 /pmc/articles/PMC8778043/ /pubmed/35049891 http://dx.doi.org/10.3390/md20010036 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Karpiński, Tomasz M. Ożarowski, Marcin Alam, Rahat Łochyńska, Małgorzata Stasiewicz, Mark What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin? |
title | What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin? |
title_full | What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin? |
title_fullStr | What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin? |
title_full_unstemmed | What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin? |
title_short | What Do We Know about Antimicrobial Activity of Astaxanthin and Fucoxanthin? |
title_sort | what do we know about antimicrobial activity of astaxanthin and fucoxanthin? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778043/ https://www.ncbi.nlm.nih.gov/pubmed/35049891 http://dx.doi.org/10.3390/md20010036 |
work_keys_str_mv | AT karpinskitomaszm whatdoweknowaboutantimicrobialactivityofastaxanthinandfucoxanthin AT ozarowskimarcin whatdoweknowaboutantimicrobialactivityofastaxanthinandfucoxanthin AT alamrahat whatdoweknowaboutantimicrobialactivityofastaxanthinandfucoxanthin AT łochynskamałgorzata whatdoweknowaboutantimicrobialactivityofastaxanthinandfucoxanthin AT stasiewiczmark whatdoweknowaboutantimicrobialactivityofastaxanthinandfucoxanthin |